Effect of Liuweidihuang decoction on sterol regulatory element binding protein -1c and liver X receptor α in the nonalcoholic fatty liver disease of rats
-
摘要: [目的]探讨六味地黄汤对非酒精性脂肪性肝病大鼠固醇调节元件结合蛋白(SREBP-1c)和肝X受体(LXR-α)的影响。[方法]选择雄性SD大鼠,随机分3组:正常组,六味地黄汤组(治疗组)和模型组。正常组喂养普通饲料,模型组和治疗组喂养高脂饲料建立非酒精性脂肪性肝病模型,治疗组并用六味地黄汤干预治疗;荧光定量RT-PCR 检测各组大鼠SREBP-1c 和LXR-α的基因表达。[结果]模型组大鼠SREBP-1cmRNA和LXR-αmRNA的相对表达均高于正常组(分别为t=2.361,P<0.05和t=3.118,P<0.01);与模型组相比,治疗组能显著降低SREBP-1cmRNA和LXR-αmRNA的表达(分别为t=3.816,P<0.01和t=3.36,P<0.01)。[结论]六味地黄汤能降低SREBP-1c和LXR-α的基因表达,改善脂质代谢。
-
关键词:
- 非酒精性脂肪性肝病 /
- 六味地黄汤 /
- 固醇调节元件结合蛋白-1c /
- 肝X受体-α
Abstract: [Objective] To explore the effect of Liuweidihuang decoction on sterol regulatory element binding protein -1c(SREBP-1c)and liver X receptor α(LXR-α)in the nonalcoholic fatty liver disease(NAFLD)of rats.[Methods] Male Sprague-Dawley rats were randomly divided into model group,treatment group,normal group.To produce a fatty liver model,a high-fat diet was given for ten weeks.The normal group rats were fed normal diet.The treatment group was given Liuweidihuang decoction while model group and normal group were given distilled water for six weeks.The expressions of SREBP-1cmRNA and LXR-αmRNA in rats liver were measured by fluorescent quantitation reverse transcription-polymerase chain raction.[Results] The expression of SREBP-1cmRNA and LXR-αmRNA in model group was higher than the normal group(t=2.361,P<0.05 and t=3.118,P<0.01 respectively).The expression of SREBP-1cmRNA and LXR-αmRNA in treatment group was lower than that of the model group(t=3.816,P<0.01;t=3.36,P<0.01 respectively).[Conclusion] Liuweidihuang decoction could reduce the expression of SREBP-1cmRNA and LXR-αmRNA in the nonalcoholic fatty liver disease of rats. -
-
[1] MAGER D,ROBERTS E.Nonalcoholic fatty liver disease[J].Can Med Assoc J,2005,173:735-735.
[2] 肖建珍,龙湘珍,冯会明,等.六味地黄汤加减治疗脂肪肝67例[J].中国实验方剂学杂志,2002,8(4):51-52.
[3] 陈国新.六味地黄丸加味治疗脂肪肝64例[J].陕西中医,2004,25(9):778-779.
[4] JUMP B D,BOTOLIN D,WANG Y,et al.Fatty acid regulation of hepatic gene transcription[J].J Nutr,2005,135:2503-2506.
[5] CHAWLA A,REPA J J,EVANS R M,et al.Nuclear receptors and lipid physiology:opening the X-files[J].Science,2001,294:1866-1870.
[6] HIGUCHI N,KATO M,SHUNDO Y,et al.Liver X receptor in cooperation with SREBP-1c is a major lipid synthesis regulator in nonalocoholic fatty liver disease[J].Hepatol Res,2008,38:782-783.
[7] WANG H,KOURI G,WOLLHEM G B.ER stress and SREBP-1 activation are implicated in beta-cell glucolipotoxicity[J].J Cell Sci,2005,118(pt17):3905-3915.
[8] 苏慧敏,张知新,潘琳,等.高脂饮食诱导幼鼠脂肪肝模型的建立及其相关代谢研究[J].中华肝脏病杂志,2010,18(1):54-58.
[9] 艾正琳,陈东风.SREBP-1c在大鼠非酒精性脂肪性肝病中的表达意义[J].第三军医大学学报,2006,28(10):1063-1065.
[10] WEI Ming-fen,王冰,程丽静,等.肝X受体的激活对小鼠糖尿病肝脏脂肪酸合成酶表达的调节[J].中华医学杂志,2008,88(12):848-852.
[11] HIGUCHI N,KATO M,SHUNDO Y,et al.Liver X receptor in cooperation with SREBP-1c is a major lipid synthesis regulator in nonalocoholic fatty liver disesse[J].Hapatol Res,2008,38:1122-1129.
[12] 艾正琳,陈东风.非酒精性脂肪性肝病大鼠肝X受体α基因表达变化及意义[J].中华肝脏病杂志,2007,15(2):127-130.
[13] 陈洁,郑瑞丹,徐成润,等.LXR-α在大鼠非酒精性脂肪肝组织中的表达及其意义[J].中华实验和临床病毒学杂志,2009,23(4):265-268.
-
计量
- 文章访问数: 136
- PDF下载数: 213
- 施引文献: 0